Meningococcal Disease: Recommended vaccinations
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 
Vaccination not funded by the National Health system
 
Mandatory vaccination
MonthsYears
234568121314152325-69101112131415161718192425≥ 26
Austria
MenB1
MenB1
MenB1
MenC2
MCV4
Belgium
MenC
Bulgaria
Croatia
Cyprus
MenC
MPSV43
Czech Republic
MenB
MCV4
MCV4
MCV4/MenB
Denmark
Estonia
Finland
France
MenC
MenC
MenC4
Germany
MenC
MenC
Greece
MenC
MenC
MCV4
MCV4
MCV4
Hungary
Iceland
MenC
MenC
Ireland
MenB
MenB
MenC
MenB
MenC5
MenC
Italy
MenB6
MenB6
MenB6
MenB6
MenC7
MCV47
Latvia
Liechtenstein
MenC8
MenC9
Lithuania
MenB
MenB
MenB
Luxembourg
MenC
MenC10
Malta
Netherlands
MCV4
MCV411
Norway
Poland
MenC
MenC
Portugal
MenC
Romania
Slovakia
Slovenia
Spain
MenC12
MenC
MenC
Sweden
United Kingdom
MenB
MenB
MenB - MenC13
MCV414
MCV414

Footnotes:

  1. Please refer to official recommendations for timing and number of doses required according to age. For infants, 3 doses from 3 months of age with at least one month interval - Booster between 12-15 months.
  2. From 12 months to 10 years of age, one dose only. Primary vaccination from 3 months possible with 1 or 2 doses according to age at first vaccination and with a booster dose according to available vaccine.
  3. vaccines only given on specific indications
  4. 1 dose until 24 years
  5. Hib/MenC combined vaccine
  6. Please refer to local recommendations for age of administration. MenB should not to be co-administered with other vaccinations.
  7. Meningococcal C vaccination, one dose for children between 13-15 months. Meningococcal ACWY, one dose for adolescents age 12-14
  8. not part of the basic vaccination plan. catch-up possible until 5 years of age
  9. not part of the basic vaccination plan. catch-up possible until 20 years of age
  10. see http://sante.public.lu/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/meningite/2018-vaccination-meningocoque-c.pdf
  11. TEMPORARY RECOMMENDATION in light of outbreak response measures: - From October 2018 (for the years 2018-2020), 13-14 year olds (in the year they turn 14 years) will be vaccinated with a MenACWY vaccine. - In 2019, one-time catch up campaign for 14-18 year olds. for further information see: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2018.23.16.18-00158 and https://www.rijksoverheid.nl/actueel/nieuws/2018/07/17/blokhuis-kondigt-grootschalige-extra-vaccinatie-aan-ruim-half-miljoen-kinderen-krijgen-oproep
  12. Depending on the vaccine used two doses can be necessary. For complete information on MenC vaccination please refer to http://www.msssi.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/docs/MenC.pdf
  13. 1 dose – Hib/MenC combined vaccine
  14. From 1 September 2015, a MenACWY conjugate vaccine replaced the MenC vaccine. for further info see https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/538503/PHE_MenACWY_Immunisation_programme.pdf and https://www.gov.uk/government/publications/meningitis-and-septicaemia-prevention-and-management-in-higher-education-institutions